Profile data is unavailable for this security.
About the company
Zhende Medical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of medical dressing products. The Company’s main products include modern wound dressings, surgical control products, traditional wound care products and pressure treatment and fixation products. The Company mainly distributes its products in domestic market and to overseas markets.
- Revenue in CNY (TTM)4.04bn
- Net income in CNY205.34m
- Incorporated1994
- Employees6.72k
- LocationZhende Medical Co LtdNo. 55 Xiangji RoadGaobu Neighborhood, Yuecheng DistrictSHAOXING 312035ChinaCHN
- Phone+86 57 588751963
- Fax+86 57 588751963
- Websitehttp://www.zhende.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hangzhou Alltest Biotech Co Ltd | 812.78m | 276.54m | 5.33bn | 1.09k | 19.21 | 1.34 | -- | 6.55 | 3.50 | 3.50 | 10.26 | 50.02 | 0.198 | 2.21 | 6.97 | 743,626.50 | 6.74 | 23.35 | 7.22 | 26.83 | 53.69 | 58.34 | 34.03 | 39.07 | 10.46 | -- | 0.0022 | 29.79 | -77.73 | 32.59 | -84.75 | 26.19 | 72.77 | -- |
Shanghai Sanyou Medical Co Ltd | 434.20m | 37.87m | 5.36bn | 466.00 | 150.61 | 2.80 | -- | 12.34 | 0.1432 | 0.1432 | 1.71 | 7.69 | 0.1951 | 0.6191 | 5.15 | 931,756.40 | 2.09 | 9.42 | 2.41 | 10.85 | 70.72 | 87.15 | 10.73 | 29.78 | 3.27 | -- | 0.0135 | 16.21 | -29.08 | 15.67 | -49.91 | 8.99 | -15.60 | -- |
Innovita Biological Technology Co Ltd | 720.40m | 332.01m | 5.87bn | 404.00 | 17.61 | 2.87 | -- | 8.15 | 2.44 | 2.44 | 5.30 | 14.98 | 0.3584 | 3.18 | 9.16 | 1,783,177.00 | 16.52 | -- | 17.42 | -- | 80.70 | -- | 46.09 | -- | 16.01 | -- | 0.001 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
Zhende Medical Co Ltd | 4.04bn | 205.34m | 6.17bn | 6.72k | 30.13 | 1.11 | -- | 1.53 | 0.7684 | 0.7684 | 15.19 | 20.95 | 0.5191 | 3.12 | 6.43 | 601,941.30 | 2.85 | 17.13 | 3.61 | 23.54 | 34.16 | 38.05 | 5.49 | 17.33 | 1.80 | 38.53 | 0.1465 | 29.85 | -32.76 | 23.63 | -70.87 | 8.79 | 21.46 | 47.58 |
Zhejiang Orient Gene Biotech Co Ltd | 825.60m | -587.36m | 6.72bn | 2.23k | -- | 0.9766 | -- | 8.14 | -2.93 | -2.93 | 4.14 | 34.13 | 0.0949 | 1.17 | 3.19 | 370,058.00 | -7.18 | 29.62 | -8.27 | 38.29 | 39.26 | 59.69 | -75.73 | 35.82 | 3.71 | -- | 0.0744 | 19.24 | -90.65 | 23.46 | -119.23 | -- | 121.04 | -- |
Shanghai Aohua Phtlctrcty Endscp Co Ltd | 750.04m | 49.97m | 7.03bn | 1.09k | 129.94 | 5.09 | -- | 9.38 | 0.4023 | 0.4023 | 5.56 | 10.27 | 0.4682 | 1.01 | 3.34 | 686,850.10 | 3.26 | 4.37 | 3.66 | 4.80 | 68.88 | 69.25 | 6.97 | 10.91 | 3.33 | -- | 0.0815 | 31.51 | 52.29 | 34.25 | 166.42 | -- | 20.42 | -- |
Shenzhen Lifotronic Technology Co Ltd | 1.19bn | 381.08m | 7.16bn | 1.48k | 18.77 | 3.67 | -- | 6.00 | 0.8909 | 0.8909 | 2.79 | 4.55 | 0.4834 | 2.27 | 7.49 | 805,792.80 | 15.37 | 13.82 | 21.09 | 16.33 | 67.06 | 61.01 | 31.79 | 26.10 | 2.25 | -- | 0.2434 | 41.51 | 16.55 | 28.78 | 30.66 | 32.27 | -7.91 | -- |
Data as of Sep 13 2024. Currency figures normalised to Zhende Medical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 4.87m | 2.14% |
Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 3.01m | 1.32% |
Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 2.44m | 1.07% |
Essence Fund Co., Ltd.as of 30 Jun 2024 | 2.09m | 0.92% |
Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 2.05m | 0.90% |
Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.95m | 0.86% |
Galaxy Asset Management Co., Ltd.as of 30 Jun 2024 | 1.31m | 0.58% |
China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2024 | 960.38k | 0.42% |
Purekind Fund Management Co., Ltd.as of 30 Jun 2024 | 937.50k | 0.41% |
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 936.00k | 0.41% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.